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Immune Clearance of Attenuated Rabies Virus Results in
Neuronal Survival with Altered Gene Expression
Emily A. Gomme1, Christoph Wirblich1, Sankar Addya2, Glenn F. Rall3, Matthias J. Schnell1,2,4*
1 Department of Microbiology and Immunology, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America, 2 Kimmel
Cancer Center, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America, 3 Fox Chase Cancer Center, Philadelphia,
Pennsylvania, United States of America, 4 Jefferson Vaccine Center, Jefferson Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of
America

Abstract
Rabies virus (RABV) is a highly neurotropic pathogen that typically leads to mortality of infected animals and humans. The
precise etiology of rabies neuropathogenesis is unknown, though it is hypothesized to be due either to neuronal death or
dysfunction. Analysis of human brains post-mortem reveals surprisingly little tissue damage and neuropathology
considering the dramatic clinical symptomology, supporting the neuronal dysfunction model. However, whether or not
neurons survive infection and clearance and, provided they do, whether they are functionally restored to their pre-infection
phenotype has not been determined in vivo for RABV, or any neurotropic virus. This is due, in part, to the absence of a
permanent ‘‘mark’’ on once-infected cells that allow their identification long after viral clearance. Our approach to study the
survival and integrity of RABV-infected neurons was to infect Cre reporter mice with recombinant RABV expressing Crerecombinase (RABV-Cre) to switch neurons constitutively expressing tdTomato (red) to expression of a Cre-inducible EGFP
(green), permanently marking neurons that had been infected in vivo. We used fluorescence microscopy and quantitative
real-time PCR to measure the survival of neurons after viral clearance; we found that the vast majority of RABV-infected
neurons survive both infection and immunological clearance. We were able to isolate these previously infected neurons by
flow cytometry and assay their gene expression profiles compared to uninfected cells. We observed transcriptional changes
in these ‘‘cured’’ neurons, predictive of decreased neurite growth and dysregulated microtubule dynamics. This suggests
that viral clearance, though allowing for survival of neurons, may not restore them to their pre-infection functionality. Our
data provide a proof-of-principle foundation to re-evaluate the etiology of human central nervous system diseases of
unknown etiology: viruses may trigger permanent neuronal damage that can persist or progress in the absence of sustained
viral antigen.
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including type I interferons, and neutralizing antibodies [3–7].
Acute infection induces global upregulation of proinflammatory
and innate immunity genes, including IL-6, TNF-a, type I
interferons, complement cascade genes, and toll-like receptors
within the brain [8–10]. Though there is some evidence that
infection induces morphologic changes in infected neurons
[11,12], there is a distinct lack of overt histopathological changes
indicative of apoptosis or necrosis [1,2]. Attempts to recapitulate
this ex vivo have been difficult; some viral strains induce neuronal
apoptosis in tissue culture, while others do not [12–18]. This
demonstrates the importance of studying neuronal cell fate in an
animal model.
An alternative hypothesis is that neuronal dysfunction, rather
than cell death, is responsible for the clinical features and fatal
outcome in rabies. Neurological abnormalities are obvious, but
studies in experimental rabies have revealed other phenomena,
including disappearance of rapid eye movement (REM) sleep and
initiation of facial twitching, called myoclonus, prior to development of classic symptoms. It was also found that brain electrical
activity terminated about 30 minutes before cardiac arrest,

Introduction
Rabies is a fatal neurological disease of animals and humans for
which there is no treatment once symptoms develop. The disease
is caused by infection of the central nervous system (CNS) with the
single-stranded RNA virus, Rabies virus (RABV). Infection results in
dramatic neurological symptoms—aggression, hyperactivity, muscle weakness, paralysis, coma—invariably leading to fatality. The
precise etiology of rabies pathogenesis is unknown and hypothesized to be either neuronal death or dysfunction. However,
whether infected neurons can survive infection and the resultant
immune response is unknown. Moreover, if these neurons survive,
whether they are functionally restored to their pre-infection
competence has not been determined in vivo for RABV, or for any
neurotropic virus.
Analysis of human brains post-mortem reveals surprisingly little
tissue damage and neuropathology, considering the dramatic
clinical symptomology [1,2]. As seen for other viral infections both
RABV replication and resultant anti-viral immune responses are
believed to be non-cytolytic; the latter mediated by cytokines,
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reporter mouse model [27]. These Cre reporter mice constitutively
and ubiquitously express membrane-targeted tandem dimer
Tomato (tdTomato); upon exposure to Cre recombinase, the
tdTomato gene is deleted, and membrane-targeted EGFP is
induced (Figure 1D). We generated a recombinant rabies virus
(RABV-Cre) expressing Cre-recombinase (Figure 1A) [28,29],
which, in combination with the Cre reporter mouse, provided a
model to permanently change the color of an infected cell from red
to green, even after the virus was cleared. Cre was modified by the
addition of a 59 nuclear localization signal to promote high
efficiency, in vivo recombination between loxP sites, and cloned into
the an empty recombinant RABV backbone previously published
as ‘‘BNSP’’ [30]. This recombinant virus is based on the SAD B19
RABV vaccine strain, which is moderately pathogenic after
intracranial inoculation [30], but known to infect neurons
efficiently [31]. Of note, to study long-term effects of RABV
infection on neurons, it was imperative to choose a viral strain that
efficiently infected the brain but that resulted in full recovery of the
host: our previous work indicated that doses of this strain could be
delivered that resulted in extensive neuronal infection, a robust
antiviral response, and no mortality [30].
RABV-Cre was recovered by standard methods [29] and the
fitness of the recombinant RABV, as well as the expression of the
inserted Cre gene, was evaluated ex vivo. BSR fibroblasts were
infected with RABV or RABV-Cre and analyzed by western blot
for protein expression (Figure 1B) as well as one-step growth
curves for viral replication (Figure 1C). These assays demonstrated
that insertion of Cre between the RABV nucleoprotein (N) and
phosphoprotein (P) genes had no effect on the rate of viral
replication, or relative viral gene expression (Figure 1B and C). To
analyze the functionality of the virus-encoded Cre, primary mouse
fibroblasts harvested from Cre reporter mice were infected with
RABV or RABV-Cre. Functional expression of Cre was indicated
by EGFP expression in Cre reporter mouse fibroblasts after
infection with RABV-Cre but not after infection with wildtype
RABV (Figure 1D and E). Of note, these cells are double-labeled
with EGFP and tdTomato; this delayed loss of tdTomato is likely
due to a long protein half-life. Published data shows loss of
tdTomato upwards of 9 days post-excision [27], though this may
vary from tissue to tissue.

Author Summary
Rabies is an ancient and fatal neurological disease of
animals and humans, caused by infection of the central
nervous system (CNS) with Rabies virus (RABV). It is
estimated that nearly 55,000 human RABV fatalities occur
each year, though this number is likely much higher due to
unreported exposures or failure of diagnosis. No treatment
has been identified to cure disease after onset of
symptoms. Neurovirologists still do not know the cause
of rabies’ dramatic symptoms and fatality, though it is
thought to be due to neuronal loss or dysfunction. Here,
we use a novel approach to permanently and genetically
tag infected cells so that they can be identified after the
infection has been cleared. This allowed us to define
neuronal survival time following infection, and to assess
neuronal function through gene expression analysis. We
found that RABV infection does not lead to loss of neurons,
but rather induces a permanent change in gene expression
that may be related to the ability of RABV to cause
permanent CNS disease. Our study provides evidence that
viral infection of the brain can initiate long-term changes
that may have consequences for nervous system health,
even after the virus has been cleared from the CNS.

indicating that cerebral death precedes organ failure [19,20]. This
correlates with functional deficiencies observed during acute
experimental RABV infection, including altered expression of
proteins involved in synapse communication and ion homeostasis
[21], as well as neuronal depolarization and decreased neurotransmitter binding [22–26].
A challenge in studying the longevity of infected neurons is
identifying and isolating them after resolution of the acute viral
infection. In the absence of a permanent ‘‘mark’’ on once-infected
cells, it is impossible to decisively answer the question as to
whether infected cells survive and regain their pre-infection
functionality. Instead, more general metrics of CNS health have
been used, including histopathological assessments, absence of cell
death (via assays with known limitations in vivo, such as TUNEL
staining), and in vitro studies using neuroblastoma cells or primary
neurons that may not faithfully recapitulate the biology of an
infected neuron in vivo. Furthermore, control of viral replication by
host immune responses in immunocompetent animal models may
limit the infection to only a few cells, and apoptotic loss of these
few cells may not be readily detected by most methods.
Here we present a novel approach to study neuronal cell fate
after RABV infection. We infected Cre reporter mice with a sublethal dose of recombinant RABV expressing Cre-recombinase
(RABV-Cre) to switch neurons constitutively expressing tdTomato
(red) to expression of a Cre-inducible EGFP (green), permanently
marking neurons that had been infected in vivo. This model
allowed us to monitor neuronal survival after infection and to
isolate neurons that resolved infection to characterize gene
expression profiles relative to uninfected neurons. Our results
support the notion that the majority of neurons survive infection,
but remain impaired; this may account for the CNS disease caused
by this neuropathogen.

RABV infection of brain neurons in Cre reporter mouse
are ‘permanently marked’ by constitutive EGFP
expression. Cre reporter mice were infected intranasally (IN)

with 105 foci forming units (ffu) RABV-Cre (Figure 2A). This sublethal dose was specifically chosen to permit the study of neuronal
survival and integrity at later time points post-infection. Infected
mice became moribund by day 15 post-infection and developed
classic signs of rabies—weight loss, fur ruffling, ataxia, hunched
posture—though none displayed hind limb paralysis (Figure 2B).
The lack of peripheral neuropathy, as seen before [32], is likely
due to the route of administration, because IN-administered
RABV directly invades the CNS without infecting the peripheral
nervous system. 65% to 75% of the infected mice survived acute
infection and regained body weight after day 15 (Figure 2B).
Cre reporter mice were maintained up to 6 months postinfection with groups of 3–4 mice being sacrificed at the time
points depicted in Figure 2A. At each time point, brains were
collected from the mice for imaging and RNA analysis. We
initially imaged brains collected from mice 15 days postinfection—a point when viral replication was still active [33,34]
and clinical signs of RABV peaked (Figure 2B). Only brain tissue
from infected mice showed regions of EGFP expression amid nontransformed tdTomato-expressing brain tissue (Figure 3 and 4).
Because the fluorophores are membrane-targeted, we were able to

Results
Recovery and characterization of Cre-expressing RABV
(RABV-Cre)
In order to identify and isolate cells (specifically, neurons) after
resolution of a viral infection, we adopted a double-fluorescent Cre
PLOS Pathogens | www.plospathogens.org
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Figure 1. Characterization of Cre-expressing RABV. A) Genome of rabies virus (RABV) and the recombinant RABV expressing Enterobacteria
phage P1 Cre recombinase (RABV-Cre) with a 59 nuclear localization signal (shown in orange). B) Cre expression was confirmed by western blot
analysis. Neuroblastoma cells were infected with either RABV-Cre, RABV expressing HIV-1 Gag (RABV-Gag), or mock infected (uninfected). Proteins
were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and subjected to Western blotting with antibodies specific for Cre,
RABV P or N, and actin. C) Viral growth kinetics were evaluated by multi-step growth curve assay in which BSR cells were infected at MOI 0.01 with
either RABV or RABV-Cre, and viral titers determined from samples taken at the indicated time points post-infection. D) A schematic depicting the
Cre-specific expression cassette in the Cre reporter mouse. In the absence of Cre, the chicken b-actin core promoter with a CMV enhancer (CAG)
drives constitutive expression of membrane-targeted tandem dimer tomato (tdTomato) expression; EGFP is not expressed. After Cre-mediated
excision of the tdTomato gene at the loxP sites, membrane-targeted enhanced green fluorescent protein (EGFP) is expressed. pA denotes
polyadenylation sites. E) Cre functionality was evaluated in vitro by infecting primary fibroblasts isolated and cultured from Cre reporter mice for
96 hours with either RABV-Cre or RABV at MOI 20. EGFP and tdTomato labeling were detected by fluorescence microscopy (top) and flow cytometry
(bottom) (using FITC and PE channels, respectively).
doi:10.1371/journal.ppat.1002971.g001

were morphologically similar across this timeline. Only the
hippocampus becomes EGFP+ later than the other regions,
between 15 days and 1.5 months post-infection, but then remains
unchanged through the rest of the time course. Moreover, the
hippocampus is the most brightly labeled anatomical region of the
brain. In contrast, the least prominent labeling was found in the
cerebellum, though these levels of labeling are clearly higher than
naı̈ve cerebellar sections. This agrees with other reports that
RABV is distributed throughout various regions of the brain,
including cerebral cortex, hippocampus, and cerebellum [34,36].
These neurons are either survivors of RABV infection, or newlyinfected cells.
To elucidate whether EGFP+ foci observed at later time points
are products of new infection or previously-infected neurons, we
used quantitative real time PCR to compare levels of viral genome
and messenger RNA to that of EGFP from the same brains used to
image the tdTomato/EGFP in Figure 5. Similar to the immunofluorescence data, EGFP RNA peaks at day 15 post-infection and
remains stably expressed through our last time point, 6 months

detect single-cell morphology including individual dendrites using
confocal microscopy (Figure 3). To further characterize the
EGFP+ regions after RABV infection, we stained for RABV P
antigen and cell-specific markers for neurons (NeuN) and
astrocytes (GFAP) (Figure 4). In vivo, RABV is known to replicate
almost exclusively in neurons [35] and rarely in glial cells [2]. As
shown in Figure 4C, we detected perinuclear RABV P amid
clusters of infected neurons only within the EGFP+ regions.
Neurons survive RABV infection and viral clearance in
vivo. Having validated that the EGFP+ regions correspond to

RABV-infected neurons, we examined the distribution and
duration of EGFP foci over the course of 6 months during which
RABV infection would have been cleared. Though rabies can be
cleared as early as 18 days post-infection [33,34], we detected
EGFP+ foci out to 6 months post-infection (Figure 5). Single
EGFP+ cells begin to appear as early as day 7 post-infection, but
stable numbers of multi-nucleated foci were present in all areas
evaluated in the brain parenchyma from day 15 through 6 months
post-infection (Figures 5 and 6). Of note, the sizes of these foci
PLOS Pathogens | www.plospathogens.org
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Figure 3. Visualization of EGFP-labeled cells from infected
mouse brains during acute infection. Fifteen days post-infection,
brains were collected, cryosectioned, and imaged without secondary
staining on a standard fluorescent microscope (206and 406images) or
confocal microscope (636 image). All images shown are from the
olfactory bulb region.
doi:10.1371/journal.ppat.1002971.g003

Microarray analysis of RABV-infected neurons isolated by
FACS 3 months after infection indicates gene
dysregulation
Neuronal survival following viral infection next prompted us to
investigate the functional integrity of these ‘‘cured cells’’. We used
fluorescence activated cell sorting (FACS) to isolate the EGFP+
population (‘‘infected’’) and the tdTomato+ population (‘‘uninfected’’) from individual mice 3 months post-infection (Supplemental Figure S1), a time when viral transcription was undetectable (Figure 7). Of note, the endogenous fluorescence of these
populations precluded the need for intracellular staining that
compromises RNA integrity. Affymetrix Gene Microarray was
used to measure transcriptional profiles of the infected and
uninfected cells from two independent cell sorting events (n = 2 for
each group). This analysis identified 1248 genes differentially
expressed between the sorted groups (infected vs. uninfected, $1.5
fold change, p,0.05), 361 genes of which were down-regulated,
887 genes that were up-regulated. Gene expression levels ranged
from 3.09-fold up-regulation to 2.72-fold down-regulation, and
only 127 genes differed by more than 2-fold (Supplemental Table
S1). Though the overall change in gene expression was modest,
these transcriptional changes may be implicated in neuronal
dysfunction. We saw no decrease in neuron-specific genes
classically down-regulated in neurological disorders; in fact, there
was up-regulation of neuronal receptors (glutamate receptor,
GABA receptor), ion channels (potassium, sodium, and hydrogen),
neurotransmitter transporter (Cacna1b), and synapse-specific
genes (synaptotagmin I, synaptophysin) (Supplemental Table S2),
strongly supporting our contention that these analyzed cells are of
neuronal origin. However, it is not a given that the change in
expression of ‘‘neuron-specific’’ genes is responsible for the
dysfunction of the neuron. More likely it is the virus’ interaction
with ubiquitous cellular genes that induces functional changes
within the neuron. For example, genes encoding proteins that play
critical roles in ion homeostasis, exocytosis, or mitochondrial
function have been shown to have a great effect on neuronal
function – however these genes are commonly expressed in a large
variety of cells. Ingenuity Pathway Analysis (IPA) was used to

Figure 2. In vivo analysis of RABV-infected cells using Cre
reporter mouse model. A) Timeline of mouse experiment. Cre
reporter mice were infected intranasally (IN) with 105 ffu RABV-Cre and
sacrificed at the specified times. B) Weights of infected mice were
monitored as a measure of disease throughout the experiment and
demonstrate productive infection in all mice within this experiment. C)
Brains collected at different time points post-infection were analyzed
for the presence of EGFP-expressing cells in the following anatomical
regions: olfactory bulb (OB), cerebral cortex (CC), cerebrum (CR),
hippocampus (HIP), cerebellum (CB) and midbrain/hindbrain (MB-HB).
doi:10.1371/journal.ppat.1002971.g002

post-infection (Figure 7). In contrast, active RABV infection, as
measured by RABV N mRNA production, peaks at day 15 postinfection and decreases thereafter, with fewer than 100 copies of
viral message detected by 3 months post-infection. This is
supported by immunohistochemical detection of RABV P at these
time points (Figure 6). While others have reported viral mRNA
peaking at days 6–8 post-infection with near complete clearance
by day 18 [33], our more sensitive quantification shows sustained
viral persistence, particularly of the genome that is still present at
approximately 1000 copies as late as 6 months post-infection
(Figure 7). It has been suggested that viral genome persistence for
negative-stranded RNA viruses is due to the stabilizing effects of
the nucleoprotein which closely encapsidates the genome, and not
necessarily to the production of new genomes. Because negativestranded RNA viruses cannot replicate without the production of
the RABV N, P, or L proteins, the lack of N mRNA clearly
indicates the lack of active replication.
PLOS Pathogens | www.plospathogens.org
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Figure 4. EGFP+ neurons are positive for RABV antigen. Brains were collected from Cre reporter mice fifteen days post-infection,
cryosectioned, and EGFP+ regions compared to cell-specific labeling, A) NeuN (blue, neuronal nuclei antibody, 206 fluorescence imaging), B) GFAP
(blue, astrocyte antibody, 406confocal imaging), or C) RABV P antigen (purple) and DAPI nuclear stain (blue, 636confocal imaging). White arrows in
(C) indicate regions positive for RABV P.
doi:10.1371/journal.ppat.1002971.g004

indirectly by infection may lead to symptoms of disease. For
example, caspase-dependent apoptosis has been implicated in
pathogenesis of vesicular stomatitis virus (VSV) and WNV, and
cytomegaloviruses induce lysis of the host cell [37–39]. For RABV,
the basis of neuropathogenesis is unknown, and predicted to be
due either to neuronal death or dysfunction.
A challenge in studying the longevity of infected neurons is
identifying and isolating them after resolution of the acute viral
infection. To study rabies, approaches used in the past have
included histopathology, measurements of cell death (via TUNEL
assay), and in vitro studies that may not represent the biology of an
infected neuron in vivo. These assays have known limitations and
may account for the inconsistent results in this research area,
making it hard to draw a conclusion as to neuronal cell fate after
viral infection. Here we examined the survival and functionality of
neurons infected with RABV using a novel and innovative

identify biological functions most significantly impacted; cell-tocell signaling was the most significant molecular and cellular
function impacted, whereas behavior and nervous system development/function were the two most significant physiological
systems impacted (Figure 8). Analyzing the regulation of groups of
related genes, IPA predicted decreased function (those with an
absolute z-score value$1.96) in the following areas: neurite
growth/outgrowth, organization of cytoskeleton, organization of
cytoplasm, and microtubule dynamics (genes involved in these
functions are listed in Table 1).

Discussion
Neurons are particularly vulnerable to the consequences of viral
infection and/or the anti-viral immune response in the brain.
Evidence suggests that neuropathology induced directly or

Figure 5. Neurons persist throughout the infected mouse brain long-after acute viral infection. The spread of the RABV infection was
detected by identifying regions of EGFP fluorescence in different neuroanatomical regions (see Figure 2C) over a 6 month time course. Images are
representative of 3–4 mice analyzed at each time point.
doi:10.1371/journal.ppat.1002971.g005
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Figure 6. RABV antigen is undetectable by immunostaining 3 months after infection. Brains from infected mice were collected at the
indicated time points and immunostained. The panels show cryosections stained for RABV P antigen (purple) and DAPI nuclear stain (blue; 636
confocal imaging). White arrows indicate regions positive for RABV P.
doi:10.1371/journal.ppat.1002971.g006

we speculate that in the rare event of an animal (or person)
surviving a RABV infection, the changes within the previous
infected neurons are similar to what have been observed for the
attenuated RABV. Though we do not have direct evidence that
infection with a pathogenic RABV will result in similar changes in
gene expression as observed here for the attenuated RABV, there
is indirect support for this hypothesis. This is based on the findings
that the major difference between a pathogenic and attenuated
RABV is the faster spread within the CNS of the pathogenic strain
[40] which, in combination with the lack of immunogenicity of the
pathogenic strain, normally results in death of the infected host.
However, the lack of any pathology within the RABV-infected
brain, which is especially true for an infection with pathogenic
RABV strain, [15,41–45] strongly argues for functional changes
within the infected neurons, including pathogenic strains.
Our results show that experimental RABV does not induce cell
loss as a result of direct or indirect cytopathic effects of the virus,
nor a cytotoxic immune response. RABV G has been implicated in
apoptotic signaling in vitro; for many years it was believed that the
quantity of RABV G expressed correlated with both apoptosis and
pathogenicity [15,46]. Recently this paradigm was challenged, and
abundance alone was shown not to be the only determinant of
apoptosis [47]. Préhaud et al. demonstrated that pathogenic and
attenuated strains recruit different intracellular proteins that
mediate either cell survival or cell death, respectively [18]. The
in vivo relevance of their work remains to be determined; in vitro
infection of pure cultures of neurons, at a high multiplicity of
infection, in the absence of an intact immune response may not
represent events in vivo. Our results indirectly support the claims
that RABV immunity is rapid and mediated by non-cytolytic
immune responses, likely antibody and cytokine secretion [4]. The
role of type I interferons, specifically, has been of great research
interest. RABV-infected neurons can produce type I interferons in
vitro [48], and interferon-a receptor knock out mice are unable to
control the virus and ultimately succumb to infection [49]. What
impact these cytokines have on neuronal integrity is unclear.
Though CD8+ T cells have been found in brain sections of human
rabies victims [50], their deletion appears to have no significant
effect on the survival of challenged mice [4].
Our data supports the hypothesis that RABV pathogenesis is
not due to loss of neurons, but rather to neuronal dysfunction.

approach: the Cre reporter mouse model. Of note, our results are
based on attenuated RABV which only models what may happen
in a natural RABV infection. We appreciate the fact that
pathogenic rabies virus is invariably lethal and few survive to the
later timepoints evaluated in this study. However, by using a less
virulent strain of virus, we were able to sufficiently infect brain
neurons without killing the mice, and study the impact of the
infection on these cells long after clearance of substantial
inflammation and bystander effects, which may complicate data
analysis. More pathogenic RABV variants could be used, though
the window of time between infection and death is brief and
catching these cells for analysis would be challenging. However,

Figure 7. Neurons survive RABV infection and viral clearance.
RNA was isolated from brains of mice at the indicated time points postinfection and assayed by real-time quantitative PCR for RABV genomic
RNA (blue circles and line; left y-axis), RABV messenger RNA (black
squares and line; left y-axis), and relative EGFP expression (green bars;
right y-axis). Gene expression of all targets was normalized to the
RPL13A (L13A) housekeeping gene. Data displayed was collected from
3 to 4 mice at each time point.
doi:10.1371/journal.ppat.1002971.g007
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Figure 8. Microarray analysis of RABV-infected neurons isolated by FACS 3 months after infection indicates dysregulation of genes
involved in nervous system function and cellular assembly. Cell suspensions prepared from whole mouse brains 3 months post-infection
were sorted on a MoFlo cell sorter for EGFP+ (previously infected) and EGFP- (uninfected) cell populations. The 1248 transcripts differentially
expressed between infected and uninfected cells ($1.5 fold change, p,0.05) were analyzed by Ingenuity Pathway Analysis (IPA) to identify biological
functions most significantly affected by the infection (significance predicted by p-value). Shown are the top ten most significant biological systems
affected by the gene dysregulation, with the horizontal bars representing the negative log of their p-value (greatest significance at the top). Below
each bar is the top three sub-categories affected by gene dysregulation in the respective categories. Each category/sub-category has the number of
genes involved (up or down-regulated).
doi:10.1371/journal.ppat.1002971.g008

functional consequences potentially induced by the pattern of gene
changes: decreased neurite growth, decreased organization of
cytoskeleton, decreased organization of cytoplasm, and decreased
microtubule dynamics. For example, we observed a downregulation of many key microtubule/microtubule-associated genes
by microarray. Our results, which were acquired through an
unbiased assay, are in agreement with others; Li et al. found
similar down-regulation of microtubule-related genes in acute
pathogenic RABV infection, and this directly correlated to
degeneration of neuronal processes [51]. Furthermore, decreased
neurite growth and dendritic/axonal swelling has been detected by
microscopic examination of infected neurons in culture
[11,12,18,51], though it may be strain dependent. Together,
these hypothesized gene expression changes may reflect an overall
failure to reorganize the cytoskeleton for growth or repair of
cellular processes. Future examination of live EGFP labeled cells
purified from the brains of these Cre reporter mice may fully
elucidate the functionality, or lack thereof, of once-infected

Evolutionarily this makes sense, as preservation of the neuronal
network by inhibition of apoptosis and limitation of inflammation
is advantageous for RABV to complete its lifecycle. The Cre
reporter model allowed us to isolate ‘‘cured’’ neurons from mice 3
months post-infection to study their transcriptional profiles
compared to uninfected cells from the same mice. Comparing
one cell population to another in the same mouse acted as an
internal control, avoiding differences based on age, treatment, and
normal biological variance. We show evidence that neurons
exhibit permanent transcriptional differences from uninfected cells
long after resolution of the viral infection. We used a bioinformatics tool, Ingenuity Pathway Analysis (IPA), to identify
biological functions most significantly impacted by this dysregulated gene set. Our results showed a modest change in gene
transcription (rarely over 3-fold difference between infected and
uninfected) with most affected genes involved in cell-to-cell
signaling and nervous system development/function. The most
interesting aspect of the transcriptional data was the prediction of
PLOS Pathogens | www.plospathogens.org
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Table 1. Dysregulated genes and predicted effect on cell functions using Ingenuity Pathway Analysis.

Functions Affected*

Predicted Effect
on Function**

Gene Description

Gene Symbol

Transcripts
Cluster ID

Fold
Change

Neur

Increased

apurinic/apyrimidinic endonuclease 1;
transmembrane protein 55b

APEX1

10414522

1.602

Cskel, Cplsm, Micr

Increased

BCL2-associated athanogene 4

BAG4

10577858

1.660

Neur

Affected

calcium channel, voltage-dependent,
P/Q type, alpha 1A subunit

CACNA1A

10573348

1.893

Cskel, Cplsm, Micr

Increased

calpastatin

CAST

10410656

21.646

Cskel, Cplsm, Micr

Decreased

cyclin-dependent kinase 5, regulatory
subunit 1 (p35)

CDK5R1

10379482

2.168

Cskel, Cplsm, Micr

Increased

cyclin-dependent kinase inhibitor 1B

CDKN1B

10542317

1.741

Cskel, Cplsm, Micr

Decreased

CLIP associating protein 1

CLASP1

10349249

1.520

Neur

Increased

cannabinoid receptor 1 (brain)

CNR1

10503902

2.179

Cskel, Cplsm

Affected

contactin associated protein-like 1

CNTNAP1

10381272

1.835

Neur, Cskel, Cplsm, Micr

Decreased

cAMP responsive element binding protein 1

CREB1

10346943

21.684

Cskel, Cplsm

Affected

colony stimulating factor 1 (macrophage)

CSF1

10501164

21.679

Cskel, Cplsm, Micr

Affected

doublecortin-like kinase 1; predicted gene 9831

DCLK1

10498204

1.630

Neur

Decreased

delta/notch-like EGF-related receptor

DNER

10356177

1.786

Cplsm

Affected

endothelial PAS domain protein 1

EPAS1

10447317

21.552

Neur

Affected

Eph receptor A4

EPHA4

10355893

1.925

Neur

Decreased

Fas apoptotic inhibitory molecule

FAIM

10588083

21.847

Cskel, Cplsm, Micr

Decreased

fibroblast growth factor 1

FGF1

10458560

22.180

Cskel, Cplsm

Affected

flightless I homolog (Drosophila)

FLII

10386551

21.537

Neur, Cskel, Cplsm

Decreased

fibronectin 1

FN1

10355403

21.637

Cskel, Cplsm, Micr

Decreased

tyrosine-protein kinase Fyn

FYN

10362596

21.688

Cplsm

Affected

glucosidase, alpha, acid

GAA

10383088

1.698

Cskel, Cplsm, Micr

Decreased

histone deacetylase 6

HDAC6

10603387

1.521

Cplsm

Affected

hexosaminidase A

HEXA

10585874

2.105

Neur

Decreased

high mobility group box 1

HMGB1

10604663

22.295

Cskel, Cplsm, Micr

Increased

huntingtin

HTT

10521261

1.909

Cskel, Cplsm, Micr

Affected

hydrocephalus inducing

HYDIN

10575380

22.241

Cskel, Cplsm, Micr

Decreased

kinesin family member 5A

KIF5A

10373113

21.671

Cplsm

Affected

kinesin family member 5B

KIF5B

10457273

21.842

Cskel, Cplsm, Micr

Decreased

kinesin light chain 1

KLC1

10398727

21.521

Cskel, Cplsm

Affected

keratin 17

KRT17

10391066

1.550
1.793

Neur

Decreased

leucine-rich repeat kinase 2

LRRK2

10426315

Cskel, Cplsm

Affected

lymphocyte specific 1

LSP1

10559207

21.590

Cskel, Cplsm, Micr

Increased

mitogen-activated protein kinase 8

MAPK8

10418879

1.716

Cskel, Cplsm

Decreased

mannoside acetylglucosaminyltransferase 5

MGAT5

10349404

1.967

Cskel, Cplsm

Affected

metastasis suppressor 1

MTSS1

10428857

21.716

Neur, Cskel, Cplsm, Micr

Decreased

myosin, heavy polypeptide 9, non-muscle

MYH9

10430201

21.774

Cskel, Cplsm

Affected

myosin IF

MYO1F

10443980

21.519

Cskel, Cplsm, Micr

Affected

NCK-associated protein 1

NCKAP1

10484318

1.721

Neur, Cskel, Cplsm, Micr

Decreased

neuropilin 1

NRP1

10576639

1.760

Cskel, Cplsm

Affected

piccolo (presynaptic cytomatrix protein)

PCLO

10519770

1.834

Neur

Decreased

phospholipase D1

PLD1

10491106

21.677

Cskel, Cplsm, Micr

Decreased

prion protein

PRNP

10476314

1.607

Cskel, Cplsm, Micr

Affected

radixin; RIKEN cDNA 9830163H01 gene

RDX

10585301

22.012

Neur, Cskel, Cplsm

Decreased

Rho-associated coiled-coil containing
protein kinase 2

ROCK2

10394731

1.920

Neur

Decreased

sparc/osteonectin, cwcv and kazal-like
domains proteoglycan 2

SPOCK2

10363415

1.554

Cskel, Cplsm, Micr

Decreased

serine/threonine kinase 11

STK11

10364683

21.902
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Table 1. Cont.

Functions Affected*

Predicted Effect
on Function**

Gene Description

Gene Symbol

Transcripts
Cluster ID

Fold
Change

Cskel, Cplsm

Affected

STE20-related kinase adaptor beta

STRADB

10346576

1.515

Neur

Decreased

synaptic Ras GTPase activating protein 1 homolog SYNGAP1
(rat)

10443108

1.762

Cskel, Cplsm, Micr

Decreased

transforming growth factor, beta 3

TGFB3

10401673

21.655

Cskel, Cplsm, Micr

Decreased

tenascin R

TNR

10350951

1.645

Neur

Decreased

tuberous sclerosis 2

TSC2

10448631

1.801

Cskel, Cplsm, Micr

Decreased

ubiquitination factor E4B, UFD2 homolog (S.
cerevisiae)

UBE4B

10518642

1.732

Cplsm

Affected

unconventional SNARE in the ER 1 homolog (S.
cerevisiae)

USE1

10572580

21.758

Neur, Cskel, Cplsm, Micr

Increased

vimentin

VIM

10469322

22.380

*Neur: growth of neurites; Cskel: organization of cytoskeleton; Cplsm: organization of cytoplasm; Micr: microtubule dynamics.
**Increased: gene expression pattern predicts an increase in the specific function; Decreased: gene expression pattern predicts a decrease in the specific function;
Affected: gene is involved in specific function, but unclear how it would influence it.
doi:10.1371/journal.ppat.1002971.t001

neurons compared to never-infected neurons. Furthermore,
alternative approaches, such as laser capture microdissection,
may be useful in future efforts to monitor transcriptional changes
in specific sub-populations of neurons.
We anticipate that an understanding of the deficiencies of
RABV infected cells will provide useful insights into the
development of novel treatment options for the acute disease
based on restoring lost cellular function. The incubation period, or
period between infection and development of symptoms, is
extremely variable and can range from 1 week to over 1 year in
duration. Post-exposure prophylaxis is highly effective during this
period; however, once symptoms develop, survival is extremely
rare. Our data provides hope that living neurons may be a possible
target for intervention. If research can elucidate the precise effect
of viral infection of brain neurons, it may be possible to develop
novel treatments effective during these late stages of disease. This
data also provides reason to be concerned with the use of
recombinant rabies vectors for treatment of neurological disorders
or infections.
This model may also be used as a tool to study the regenerative
capacity of neurons. We looked at neuronal gene expression from
one time point only, but analyzing the expression of select genes at
several points over a period of time would provide information
regarding the ability of these cells to regenerate. Furthermore,
viral genome was still present at the 3 month timepoint; is
functionality regained after complete genome clearance? Latent
herpesvirus induces neuronal deficits, though this is likely due to
transcription of latency-associated genes [52]. We believe that the
RABV genome is persisting due to the stabilizing effects of the
viral nucleocapsid as described for other negative-stranded RNA
viruses, including VSV [53], and RABV does not express latencyassociated genes. We do not anticipate that the persistent genome
will play a role in neuronal dysfunction, though this would need to
be confirmed experimentally.
Lastly, this model may be used to study the link between viral
infection and chronic neurodegenerative diseases. This link has
been suggestive for other abortive or latent viral infections in
which the host survives (e.g. herpesviruses, measles, Polio, EpsteinBarr). Multiple sclerosis, for example, is suspected by some of
having a viral etiology. A virus-induced disturbance may be, in a
subset of patients, the starting point for autoimmune demyelinPLOS Pathogens | www.plospathogens.org

ation. There is compelling evidence for involvement of Human
herpesvirus 6 (HHV-6), as viral antigen has been found in sclerotic
lesions, and virus-specific IgM antibodies increase in relapsingremitting MS patients [54], though proving a causative link
between viral infection and chronic dysfunction has been difficult.
The Cre mouse model proposed here provides a powerful tool to
study other neurotropic viruses and show causation between virus
and chronic disease. Our data clearly demonstrates that neurotropic viral infection can cause persistent neurological deficits long
after active infection has been cleared, and that once-infected
neurons may not be restored to their pre-infection phenotype. The
implications of these findings are substantial, as surviving neurons,
which have a remarkable capacity to recover following damage
[55,56], may be targeted for novel treatment options in rabies and
other neurological infections by restoring compromised cellular
functions.

Materials and Methods
Mice
All animals were handled in strict accordance with good animal
practice as defined by the relevant international (Association for
Assessment and Accreditation of Laboratory Animal Care
(AAALAC) (Accreditation Status TJU: Full)) and national (TJU
Animal Welfare Assurance Number: A3085-01), and all animal
work was approved by the Institutional Animal Care and Use
Committee (IACUC) at Thomas Jefferson University TJU. Animal
use protocols are written and approved in accordance with Public
Health Service Policy on Humane Care and Use of Laboratory
Animals, The Guide for the Care and Use of Laboratory Animals.
TJU IACUC protocol number 414 I (Pathogenesis of rabies virus
and vaccine vectors in mice) was utilized in this study. Cre reporter
mice, strain B6.129(Cg)-Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J,
were purchased from the Jackson Laboratory, USA. Heterozygotes were bred and offspring were genotyped as recommended by
Jackson Laboratories.

Mouse infection
Mice were anesthetized with 4% isoflurane by inhalation and
inoculated intranasally with 16105 ffu virus diluted to 20 mL with
phosphate-buffered saline (PBS)(10 mL per nostril). Mice were
9
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0.02% bromophenol blue) at 56uC. Five micrograms of protein
were resolved on an SDS-10% polyacrylamide gel and transferred
to a nitrocellulose membrane in Towbin buffer (192 mM glycine,
25 mm Tris, 20% methanol). The membrane was then blocked in
TBST (100 mM Tris-HCl pH7.9, 150 mM NaCl, 0.01%
Tween20) containing 5% dried milk at 4uC for several hours.
After blocking, the membrane was incubated overnight with rabbit
anti-Cre polyclonal antibody (Novagen, 69050) at a dilution of
1:10,000, anti-RABV serum from reconvalescent RABV-infected
mice diluted 1:6,000, and a mouse monoclonal antibody against
Actin (Sigma, A5441), all diluted 1:250,000 in TBST containing
5% BSA. After washing, the blot was incubated for 1 h in antirabbit-HRP conjugate and anti-mouse-HRP conjugate, both
diluted 1:50,000 in blocking buffer. Bands were developed with
SuperSignal West Pico Chemiluminescent substrate (Pierce,
34080).

sacrificed at the indicated time points post-infection and brain
tissue harvested for RNA and immunohistochemistry.

Construction, recovery, and characterization of Creexpressing RABV
cBNSP is an infectious clone based on the RABV vaccine strain
SAD B19, which contains two single restriction sites (BsiWI and
NheI) for inserting foreign genes [30]. Enterobacteria phage P1
Cre Recombinase (Genbank accession number X03453) was
engineered to include a 59 nuclear localization signal (ATG
GCA CCC AAG AAG AAG AGG AAG) to promote high
efficiency in vivo recombination between loxP sites, and is hereafter
referred to simply as Cre (Cre cDNA was kindly provided by Dr.
Jianke Zhang, Thomas Jefferson University, Philadelphia). The
Cre gene was amplified using forward primer 59-cac CGT ACG
acc atg gca ccc aag aag aag-39 (BsiWI site in caps, ATG start
codon for the nuclear localization signal is underlined) and reverse
primer 59-cga GCT AGC cta atc gcc atc ttc cag cag g-39 (NheI site
in caps), and cloned into cBNSP using the unique BsiWI and NheI
sites between RABV nucleoprotein (N) and phosphoprotein (P).
The resulting cDNA was termed RABV-Cre. RABV-Cre was
recovered as previously described [30].
Multi- and single-step growth curves were conducted on BSR
cells as previously described [29]. Cre functionality was evaluated
in vitro by infecting primary fibroblasts cultured from Cre reporter
mice. To isolate primary fibroblasts, leg muscle was dissected from
euthanized adult Cre reporter mice and dissociated using a
protocol adapted from Blau et al. [57]. Briefly, muscle tissue was
minced into 3- to 4-mm pieces in PBS, incubated in an enzyme
mixture of collagenase D (0.75 units/mL, Roche Applied Science,
11088858001), Dispase II (1.2 units/mL, Roche Applied Science,
10295825001), and 2.5 mM CaCl2 for 45 min in a 37uC water
bath, triturating with a 5 mL pipette 3 times throughout the
incubation. Ten milliliters of PBS was added to the cell suspension
and passed through a 70 mm filter, spun at 3006g for 5 min,
resuspended in DMEM supplemented with 10% FBS and
penicillin-streptomycin (DMEM10), and plated in a standard
T75 tissue culture flask. To enrich for fibroblasts, cells were
allowed to attach to the flask for 1 h at 37uC, at which time the
unattached cells were aspirated and the adherent cells were
passaged in DMEM10 for 5 to 7 d. Cre reporter primary
fibroblasts plated at 80–90% confluency in 6-well plates were
infected with 2.46106 ffu recombinant virus at 37uC. After 96 h,
the cells were assayed for color change from TdTomato to EGFP
by fluorescent imaging and flow cytometry. For imaging, plated
cells were fixed with 4% PFA (pH 7) for 20 min at 4uC and viewed
under a fluorescence microscope. For flow cytometry, trypsinized
cells were fixed in suspension with 4% PFA (pH7) for 20 min at
4uC, washed once in PBS supplemented with 2% BSA, and
analyzed on a BD FACSCalibur (50,000 events collected).

Tissue harvest
Immediately after dissection, the mouse brains were bisected
laterally using a sterile scalpel. One half was immediately
immersed in RNAlater (Qiagen, 1 mL/100 mg tissue) for the
purpose of RNA isolation. The second half was placed in 4% PFA
(pH 7.0) for immunohistochemical analysis.

Immunohistochemistry
Immediately after dissection, brains were fixed 24 h in 4%
paraformaldehyde (pH 7.0) and cryoprotected by sequential
saturations in 10%, 20%, and 30% sucrose/PBS (each for 24 h).
Samples were embedded, frozen, and cut by the Kimmel Cancer
Center’s Pathology Core Facility. Brains were embedded in
Tissue-Tek O.C.T. compound (Sakura), frozen and cut at 220uC
on a Microm HM550 cryostat (Thermo Scientific) into 10 mm
sections, and mounted onto charged slides (Thermo Scientific
Superfrost Plus). Slides were stored at 220uC and either directly
imaged or stained for cell- and virus-specific antigens and then
imaged. In preparation for staining, sections were permeabilized in
0.2% TritonX-100/PBS for 1 h at room temperature (RT),
washed in 0.05% TritonX-100/PBS (wash buffer), and blocked in
wash buffer supplemented with 5% BSA. For neuronal staining,
slides were stained with a 1:100 dilution of mouse anti-NeuN
(MAB377; Millipore), washed 36, stained with 1:300 dilution of
Pacific Blue goat anti-mouse (P-10993; Invitrogen). For astrocyte
staining, slides were stained with a 1:250 dilution of rabbit antiGFAP (NB300-141; Novus), washed 36, stained with 1:300
dilution of Pacific Blue goat anti-rabbit (P-10994; Invitrogen). For
RABV P staining, slides were directly stained with a 1:300 dilution
of AlexaFluor647 mouse anti-RABV P antibody. This antibody
was generated by conjugating AF647 (A20173; Invitrogen) to
purified RABV P-specific IgG produced from hybridoma cells
kindly provided by Dr. Danielle Blondel, Gif sur Yvette, France
[58]. Specifically, antibody-containing supernatant was purified
using Nunc ProPur Midi G Kit, dialyzed in PBS, and conjugated.
Images were acquired using a Leica DM5000B fluorescence
microscope equipped with the DFC340FX camera or a Zeiss LSM
510 META Confocal microscope.

Immunoblotting
NA cells plated at 80–90% confluency in 12-well plates were
infected with 36106 ffu recombinant virus at 37uC in serum-free
media. After 1 h, inoculum was replaced with RPMI supplemented with 5% FBS and penicillin-streptomycin and incubation was
continued at 34uC. After 48 h, the cells were washed in PBS, lysed
on ice in RIPA buffer (25 mM Tris pH 7.5, 150 mM NaCl, 1%
NP-40, 0.4% sodium deoxycholate, 1 mM EDTA) containing 16
protease inhibitor cocktail (Sigma), and centrifuged at 12,0006g
for 10 min. The protein concentration in the supernatant was
determined using a BCA kit (Pierce, 23227) and the supernatants
were denatured with urea buffer (125 mM Tris–HCl pH 6.8, 8 M
urea, 4% sodium dodecyl sulfate, 5% beta-mercaptoethanol,
PLOS Pathogens | www.plospathogens.org

RNA isolation
Brain tissues immersed in RNAlater were transferred to RLT
Buffer (Qiagen) supplemented with beta-mercaptoethanol (10 mL
BME/1 mL RLT) at a ratio of 100 mL RLT-BME per 10 mg
tissue. Tissue was homogenized with Hard Tissue Omni Tip
probes (Omni International). RNA was isolated using the
RNAeasy Mini Kit (Qiagen) according to the manufacturer’s
protocol. A 15 min on-column DNaseI digest (Qiagen) was
10
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[60,61]. Brain tissue was minced into 3- to 4-mm pieces in
Earle’s Balanced Salt Solution (EBSS, HyClone, SH3002902).
Papain enzyme (Worthington Biochemical, LS003126) was
preactivated in EBSS/0.5 mM EDTA/1 mM L-cysteine by
incubating 10 min at 37uC. Minced tissue was incubated in 20
units/mL preactivated papain and 125 units/mL DNase I
(Worthington Biochemical, LS002006) for 85 min in a 37uC
water bath, triturating gently with a 10 mL pipette twice
throughout the incubation. The cell suspension was passed
through a 70 mm filter, spun at 3006g for 5 min, and
resuspended in 3 mL of dilute protease inhibitor solution (EBSS,
1 mg/mL ovomucoid inhibitor [Worthington Biochemical,
LS003085], 1 mg/mL BSA, 125 units/mL DNase I). A
discontinuous density gradient was made by layering the cell
suspension on top of 5 mL concentrated protease inhibitor
(EBSS, 10 mg/mL ovomucoid inhibitor, 10 mg/mL BSA) and
centrifuging at 706g for 8 min to separate cells (pellet) from
debris (supernatant). Cells were washed once in PBS supplemented with 2% BSA, and FACS-purified based on EGFP and
TdTomato fluorescence utilizing a Coulter MoFlo sorter. EGFPpositive and EGFP-negative populations were saved for RNA
extraction.

included for all samples during the purification. RNA concentration and purity were determined using the NanoDrop 2000c
(Thermo Scientific).

Reverse transcription and real-time quantitative PCR
RNA was reverse transcribed into cDNA using the Omniscript
Reverse Transcription Kit (Qiagen) according to the manufacturer’s protocol. Each 20 mL reaction contained 2 mg of purified
RNA, 10 units RNaseOut ribonuclease inhibitor (Invitrogen), and
0.5 mM primer. Reaction mixtures were incubated at 37uC for
1 h, followed by 5 min at 95uC to inactivate the enzyme. All
primers/probes used throughout were designed using SigmaAldrich’s OligoArchitect and purchased from Sigma-Genosys.
The following reverse transcription primers were used, 59 to 39:
RV-N genome (CAT GGA ACT GAC AAG AGA), messenger
RNA (for subsequent QPCR of RV-N sense message; TTT TTT
TTT TTT TTT TTT TTV; V = G, C, or A), EGFP (CGG ATC
TTG AAG TTC ACC), RPL13A housekeeping gene (CTT TTC
TGC CTG TTT CCG TA; part of MHK-1 primer set from
RealTimePrimers.com). Quantitative analysis of all genes was
conducted on the MX3005P QPCR Machine (Agilent Technologies). All genes (except RPL13A, described below) were
quantified using the QuantiFast Probe PCR Kit containing
ROX internal reference dye (Qiagen, 204256) according to the
manufacturer’s protocol. Each of these 20 mL reactions contained
2 mL of the reverse transcription reaction, 0.4 mM each primer,
and 0.2 mM TaqMan probe. QPCR cycling began with one hot
start cycle of 95uC for 15 min, followed by 45 amplification cycles
of 95uC for 15 sec, and 60uC for 1 min (data acquired at end of
each step). RPL13A was quantified using Brilliant II SYBR Green
QPCR Master Mix (Agilent; 600828) according to the manufacturer’s protocol. Each of these 20 mL reactions contained 2 mL of
the reverse transcription reaction and 0.1 mM each primer. QPCR
cycling began with one cycle of 95uC for 15 min, followed by 45
cycles of 95uC for 30 sec, 58uC for 1 min (data acquired at end of
this step), and 72uC for 30 sec. Sequences of the QPCR forward
primer, reverse primer, and TaqMan probe (respectively) are as
follows, 59 to 39: RV-N anti-sense genome and RV-N sense
message (CAT GGA ACT GAC AAG AGA, TGC TCA ACC
TAT ACA GAC, [6-FAM]ATG CGT CCT TAG TCG GTC
TTC TC[TAMRA]), EGFP (AGC TGG AGT ACA ACT ACA,
CGG ATC TTG AAG TTC ACC, [6-FAM]ATG CCG TTC
TTC TGC TTG TCG[TAMRA]), RPL13A housekeeping gene
(ATG ACA AGA AAA AGC GGA TG, CTT TTC TGC CTG
TTT CCG TA, [no probe]; primers from MHK-1 primer set from
RealTimePrimers.com). Primer pairs for all genes were validated
by measuring product linearity (R2.0.99) and amplification
efficiency (E = 98–102%). SYBR Green reactions were further
validated for specificity by running dissociation curves after
quantification (using default program on MX3005P) and by
running PCR products on 2.5% agarose gel. All samples were run
in triplicate alongside negative controls (water and No RT). For
absolute quantification of RV-N anti-sense genome and RV-N
sense message, an eight point standard curve was generated from
10-fold serial dilutions of cDNA of known copy number (ranging
108 to 101 transcripts). Copy numbers were normalized to
RPL13A housekeeping gene. For relative quantification of EGFP,
the DDCt method [59] was used to measure fold-change of EGFP
relative to RPL13A housekeeping gene.

RNA purification and cDNA amplification
RNA was isolated using the RNAeasy Mini Kit (Qiagen)
according to the manufacturer’s protocol. RNA was quantified
on a NanoDrop 2000c (Thermo Scientific), followed by RNA
quality assessment on an Agilent 2100 Bioanalyzer (Agilent,
Palo Alto, CA, USA). Amplification and labeling was performed
using the Ovation Pico WTA-system V2 RNA amplification
system (NuGen Technologies, Inc.). Briefly, 50 ng of total RNA
was reverse transcribed using a chimeric cDNA/mRNA primer,
and a second complementary cDNA strand was synthesized.
Purified cDNA was then amplified with ribo-SPIA enzyme and
SPIA DNA/RNA primers (NuGEN Technologies, Inc.). Amplified DNA was purified with Qiagen MinElute reaction
cleanup kit. The concentration of Purified ST-cDNA was
measured using the Nanodrop. 2.5 mg ST-cDNAs were
fragmented and chemically labeled with biotin to generate
biotinylated ST-cDNA using FL-Ovation cDNA biotin module
V2 (NuGen Technologies, Inc.).

Microarray
Affymetrix gene chips, mouse gene 1.0 ST array (Affymetrix,
Santa Clara, CA), were hybridized with fragmented and biotinlabeled target (2.5 mg) in 110 ml of hybridization cocktail. Target
denaturation was performed at 99uC for 2 min and then 45uC for
5 min, followed by hybridization for 18 h. Arrays were then
washed and stained using Genechip Fluidic Station 450, and
hybridization signals were amplified using antibody amplification
with goat IgG (Sigma-Aldrich) and anti-streptavidin biotinylated
antibody (Vector Laboratories, Burlingame, CA, USA). Chips
were scanned on an Affymetrix Gene Chip Scanner 3000, using
Command Console Software. Background correction and normalization were done using Iterative Plier 16 with GeneSpring
V11.5 software (Agilent, Palo Alto, CA, USA). 1.5-fold differentially expressed gene list was generated. The differentially
expressed gene list was loaded into Ingenuity Pathway Analysis
(IPA) 5.0 software (http://www.ingenuity.com) to perform
biological network and functional analyses. The microarray data
can be accessed at the GEO - repository access number
GSE38975 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc =
GSE38975)

Brain tissue dissociation and EGFP+ FACS purification
Whole brains with olfactory bulbs attached were dissected from
adult (.8 wks) Cre reporter mice and dissociated using a welldescribed protocol adapted from Huettner and Baughman
PLOS Pathogens | www.plospathogens.org
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Table S2 Microarray analysis of RABV-infected neurons 3 months after infection. The table shows ‘‘neuronspecific genes’’ up- or down-regulated in RABV infected Cremice.
(XLSX)

Supporting Information
Figure S1 Fluorescence-activated cell sorting (FACS) of brain
cells isolated from infected or naive Cre reporter mice three
months post-infection. EGFP+ cells were collected from the
‘‘infected’’ gate and used for gene expression analysis.
(TIFF)
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